StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.61+0.00 (+0.19%)

Close on Nov 13, 2026Market cap $2.92MP/E –Yield –

Bluejay Diagnostics gross margin

Gross margin is gross profit as a percentage of revenue.

Bluejay Diagnostics's gross margin for the twelve months ending Dec 31, 2022 was 19.6%. For fiscal 2022 it was 19.6%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 202219.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2022Jun 30, 202219.6%–

More Bluejay Diagnostics figures

See a number that looks wrong?